Observational studyDigestive diseases and sciences2026
Improvement in the Visibility of Submucosal Layers and Vessels with Amber-Red Color Imaging in Colorectal Endoscopic Submucosal Dissection.
Observational study in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimAmber-red colour imaging (ACI) (Fujifilm), a novel observational mode, was developed to visualise submucosal vessels. This study evaluated vessel and submucosal layer visibility using ACI during colorectal endoscopic submucosal dissection (ESD).
methodsThis observational study reviewed consecutive patients undergoing colorectal ESD from January 2021 to June 2025. Therapeutic outcomes of 72 ACI cases were compared with 505 white light imaging (WLI) cases. The primary outcome of this study was the mean number of intraoperative bleeding (IB) events during ESD between cases with ACI and those with WLI. The secondary outcomes were various therapeutic outcomes of ESD. Additionally, fifteen endoscopists from four countries (seven experts, eight non-experts) evaluated the visibility in ACI and WLI images during ESD using a four-point scale (Score 1 = poor to Score 4 = excellent).
resultsAmong 72 cases (mean age: 67.3 ± 11.9 years, male proportion: 48.6%), the en bloc resection rate was 98.6%. The ACI group showed fewer IB events than the WLI group (2.0 ± 2.5 vs 2.7 ± 3.4, p = 0.040), significant only among non-experts (1.5 ± 2.0 vs. 2.6 ± 3.1, p = 0.009). Regarding image evaluations, ACI achieved higher visibility scores (median [interquartile]) for vessels (4 [3-4] vs. 3 [2-3], p < 0.001), submucosa (4 [3-4] vs. 3 [2-4], p < 0.001), and muscle layer (3 [2-4] vs. 2 [2-3], p < 0.001). The rates of Score 3 + 4 for vessels, submucosa, and muscle layer were significantly higher in ACI than those in WLI regardless of endoscopists experiences.
conclusionACI may contribute to enhance the safety of colorectal ESD by reducing IB and improving the visibility of vessels and submucosa.
Indexed as
Identifiers
41689686What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.